Navigation Links
Developing policy on moving threatened species called 'a grand challenge for conservation'
Date:7/17/2012

Managed relocationthe act of purposely relocating a threatened species, population, or genotype to an area that is foreign to its natural historyis a controversial response to the threat of extinction resulting from climate change. An article in the August 2012 issue of BioScience by Mark W. Schwartz and his colleagues reports on the findings of the Managed Relocation Working Group, an interdisciplinary group of scientists, researchers, and policymakers whose goals were to examine the conditions that might justify the use of managed relocation and to assess the research being conducted on the topic. The authors note that although traditional management strategies are not likely to address the effects of climate change adequately, guidelines and protocols for managed relocation are poorly developed. "Developing a functional policy framework for managed relocation is a grand challenge for conservation," they assert.

Moving a species to a higher elevation, for instance, may allow it to survive rising temperatures or an elevated sea level, but doing do in an ethically acceptable way is fraught with both legal and political complications. Unforeseen environmental consequences of such an action may be severethe species might become invasive in its new location, for example. Some question the appropriateness of conserving a single species at the expense of possibly disrupting an entire ecosystem. What is more, lax regulation of managed relocation may open the door to exploitative movement of species. Regulation is often dispersed among states, the federal government, and various agencies, which may have conflicting agendas, and most relevant policies and laws were not written with climate change in mind.

The current state of ecological knowledge is such that predicting accurately the effects of any particular proposed relocation is difficult and likely to remain so for the foreseeable future. This makes it hard to know which species are most
'/>"/>

Contact: Tim Beardsley
tbeardsley@aibs.org
703-674-2500 x326
American Institute of Biological Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. Developing world has less than 5 percent chance of meeting UN child hunger target, study estimates
2. UMass Amherst biochemists developing tools to stop plague and other bacterial threats
3. VTT and GE Healthcare developing novel biomarkers to predict Alzheimers disease
4. Agricultural expert outlines path for developing nations to double food production, meet 2050 demand
5. Medbox Developing a Patent Pending Wall-Mounted Biometric Kiosk for Storage of Sensitive Medicine Samples and Supplies for Doctors Offices.
6. Research4Life greatly expands peer-reviewed research available to developing world
7. Family history of liver cancer increases risk of developing the disease
8. UCSD researchers: Where international climate policy has failed, grassroots efforts can succeed
9. Towards an agroforestry policy in Indonesia
10. APS issues new policy requiring identification of sex or gender in reporting scientific research
11. Researchers moving towards ending threat of West Nile virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... 2015  Trovagene, Inc. (NASDAQ: TROV ), ... the launch of a study that aims to ... (PCM) technology for predicting response to treatment in ... of the novel immunotherapy agents Yervoy® (ipilumumab), a ... The 50-patient study will be led by researchers ...
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ) ... Biometrics Market by Application, Technology, Function & Geography - ... The next generation biometrics market is expected ... of 17.9% between 2015 and 2020 Travel ... Safran SA ( France ), ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3
... used peas to show that one copy of a gene (allele) ... In the progeny, the inherited genes are expressed at the right ... thought that although gene products could be modified during the life ... mutation. Now it appears that one copy of some ...
... ELECTRONIC 222 TO ORDER CLASS II ... ... the leading,provider of outsourced hospital pharmacy I.V. compounded solutions, has,expanded ... ordering of Schedule II,Controlled Substances versus the more time-consuming traditional ...
... May Concern Law Enforcement Departments, TAMPA, Fla., ... STIY), the leader in electro-stun technology, today,announced that ... purchased Taser brand stun products an opportunity to ... devices in exchange,for price concessions., Ron Bellistri, ...
Cached Biology News:Genome communication 2Genome communication 3Genome communication 4PharMEDium Announces National Rollout of Electronic 222 Ordering Initiative 2Stinger Systems To Offer Taser Trade-In Program 2
(Date:7/28/2015)... July 28, 2015 Deerfield Management Company, L.P. ... Fund, L.P., which will invest in groundbreaking advancements in ... diseases, cancer, and orphan diseases. The venture capital fund ... therapeutics are developed and improve the way healthcare is ... the largest healthcare-focused venture funds in the sector, will ...
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix Inc. ... 1 clinical trial with MMI-0100, a first-in-class inhibitor ... developed for pulmonary disorders characterized by inflammation and ... United Kingdom , is a double-blind, two-way ... the safety and tolerability of MMI-0100 when given ...
(Date:7/28/2015)... 28, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... has granted to German life sciences entrepreneurs with ... commercialization of biotechnology (collectively, the "Optionee"), an option ... tumor vaccine technology (the "Technology"), including AEZS-120, the ... is ready to enter a Phase 1 clinical ...
(Date:7/28/2015)... 2015  Faced with increasing challenges such as ... than symptomatic, the global healthcare industry today is ... of curing or significantly changing the course of ... towards regenerative medicine as a viable alternative. ... human health with the potential to resolve unmet ...
Breaking Biology Technology:Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5
... Vincis inventions, such as this barrel spring, are old enough ... never produced. Over the past decade, the economy has ... assets, such as patents. A patent for a novel medical ... tool to facilitate rational drug design in the pharmaceutical industry ...
... productivity and communications tools now ubiquitous, organizations of ... to promote more effective communication and collaboration among ... role in organizations, the belief that technology by ... and behavior of an organization, particularly a dysfunctional ...
... developer to describe a Web site, youre likely to learn about ... youre likely to learn a lot about pinball. , ,A pinball ... works not the mechanical side of working that involves ASP, ... attracts and retains customers. By thinking of the Internet as a ...
Cached Biology Technology:Patent essentials for business owners: from patent to profit 2Patent essentials for business owners: from patent to profit 3Patent essentials for business owners: from patent to profit 4Patent essentials for business owners: from patent to profit 5Dont rely on information technology to change corporate culture 2Dont rely on information technology to change corporate culture 3My 50 cents: Web sites and pinball machines 2My 50 cents: Web sites and pinball machines 3My 50 cents: Web sites and pinball machines 4
... FDSS6000 System is an imaging based ... development and high throughput screening which ... modalities., The Hamamatsu light sources and ... companys decades-long experience in photon detection ...
... reagents and supplies, for 10 chips, ... to perform standard-sensitivity RNA analysis (nanogram ... Experion automated electrophoresis system. Supplied are ... RNA StdSens stain, 20 microliters RNA ...
... 3-(3,5-Dibromo-4-hydroxy-benzoyl)-2-ethyl-benzofuran-6-sulfonicacid-(4-(thiazol-2-ylsulfamyl)-phenyl)-amide White solid. PROTECT FROM ... cell-permeable sulfanamido-benzbromarone compound that acts as ... inhibitor of PTP1B (IC 50 ... for PTP1B 403 and PTP1B ...
Anti-NCAPD3 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunoprecipitation, Western Blot...
Biology Products: